Skip to main content
NCBI home page
Gut logoLink to Gut
. 1974 Sep;15(9):725–727. doi: 10.1136/gut.15.9.725

An evaluation of the rosette inhibition test in Crohn's disease

J R Clarke, E R Richens, M J Williams, K R Gough, R J Ancill
PMCID: PMC1413032  PMID: 4435587

Abstract

Serial rosette inhibition tests were performed on nine patients with Crohn's disease undergoing immunosuppressive therapy in an attempt to estimate the minimum amount of drug necessary to maintain immunosuppression. The rosette inhibition titre was found to be higher in immunosuppressed patients than in normal subjects. However, there was no consistent correlation of the rosette inhibition titre with the degree of activity of the disease. The test is therefore not sufficiently discriminative to be used as a basis on which to control drug dosage.

Full text

PDF
725

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bach J. F., Antoine B. In vitro detection of immunosuppressive activity of anti-lymphocyte sera. Nature. 1968 Feb 17;217(5129):658–659. doi: 10.1038/217658a0. [DOI] [PubMed] [Google Scholar]
  2. Bach J. F., Dardenne M., Dormont J., Antoine B. A new in vitro test evaluating anti-lymphocyte serum potency. Transplant Proc. 1969 Mar;1(1):403–407. [PubMed] [Google Scholar]
  3. Bewick M., Ogg C. S., Parsons V., Snowdon S. A., Manuel L. Further assessment of rosette inhibition test in clinical organ transplantation. Br Med J. 1972 Aug 26;3(5825):491–494. doi: 10.1136/bmj.3.5825.491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chapel H. M. The effects of papain, trypsin and phospholipase A on rosette formation. Transplantation. 1973 Mar;15(3):320–325. doi: 10.1097/00007890-197303000-00009. [DOI] [PubMed] [Google Scholar]
  5. Cullum P. A., Bewick M., Shilkin K., Tee D. E., Ayliffe P., Hutchison D. C., Laws J. W., Mason S. A., Reid L., Hugh-Jones P. Distinction between infection and rejection in lung transplantation. Br Med J. 1972 Apr 8;2(5805):71–74. doi: 10.1136/bmj.2.5805.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Editorial: Cytotoxic drugs and lupus nephritis. Br Med J. 1973 Oct 6;4(5883):6–6. doi: 10.1136/bmj.4.5883.6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Farid N. R., Munro R. E., Row V. V., Volpé R. Rosette inhibition test for the demonstration of thymus-dependent lymphocyte sensitization in Grave's disease and Hashimoto's thyroiditis. N Engl J Med. 1973 Nov 22;289(21):1111–1117. doi: 10.1056/NEJM197311222892104. [DOI] [PubMed] [Google Scholar]
  8. Jondal M., Holm G., Wigzell H. Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells. J Exp Med. 1972 Aug 1;136(2):207–215. doi: 10.1084/jem.136.2.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Munro A., Bewick M., Manuel L., Cameron J. S., Ellis F. G., Boulton-Jones M., Ogg C. S. Clinical evaluation of a rosette inhibition test in renal allotransplantation. Br Med J. 1971 Jul 31;3(5769):271–276. doi: 10.1136/bmj.3.5769.271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ommaya A. K., Yarnell P. Subdural haematoma after whiplash injury. Lancet. 1969 Aug 2;2(7614):237–239. doi: 10.1016/s0140-6736(69)90005-1. [DOI] [PubMed] [Google Scholar]
  11. Rhodes J., Bainton D., Beck P., Campbell H. Controlled trial of azathioprine in Crohn's disease. Lancet. 1971 Dec 11;2(7737):1273–1276. doi: 10.1016/s0140-6736(71)90598-8. [DOI] [PubMed] [Google Scholar]
  12. Willoughby J. M., Beckett J., Kumar P. J., Dawson A. M. Controlled trial of azathioprine in Crohn's disease. Lancet. 1971 Oct 30;2(7731):944–947. doi: 10.1016/s0140-6736(71)90268-6. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES